Analysis Life Sciences Thank You What We Expect the FDA to do in December 2023
Agency IQ
DECEMBER 1, 2023
To implement that authority, FDA published a final rule in the Federal Register on September 15, 2015 [80 FR 55237] which revised 21 CFR 1.94 to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. to include devices.
Let's personalize your content